FDA Inspection 740701 — Centaur Pharmaceuticals Private Ltd.

Centaur Pharmaceuticals Private Ltd. — FEI 3003973520

The FDA completed an inspection of Centaur Pharmaceuticals Private Ltd. on August 11, 2011 in Thane. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 11, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Thane (India)